New hope for liver patients: could carvedilol outperform standard care to stop deadly rebleeding?
NCT ID NCT07352228
First seen Jan 25, 2026 · Last updated May 23, 2026 · Updated 17 times
Summary
This study compares two drugs, carvedilol and propranolol, to see which is better at preventing another bleeding episode in people with liver cirrhosis who have already had variceal bleeding. About 350 adults aged 18-75 will receive endoscopic treatment plus one of the drugs. The goal is to find a safer, more effective way to reduce rebleeding and improve survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REBLEEDING OF PORTAL HYPERTENSION IN LIVER CIRRHOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The First Affiliated Hospital of Air Force Medical University
Xi'an, China
Conditions
Explore the condition pages connected to this study.